Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4823 |  BGMS Bio Green Med Solution, Inc. - Common Stock | 0.82 USD | -3.53% | -6.82% | -4.65% | -82.66% | 5.43 M USD | ||
| 4833 |  CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 USD | +14.74% | +9.67% | +17.11% | +68.94% | 5.08 M USD | ||
| 4837 |  XBIO Xenetic Biosciences, Inc. - Common Stock | 2.12 USD | -4.07% | -7.83% | -48.92% | -75.60% | 4.97 M USD | ||
| 4838 |  LIMN Liminatus Pharma, Inc. - Class A Common Stock | 3.69 USD | -4.65% | -1.60% | +2.50% | +136.54% | 4.96 M USD | ||
| 4845 |  NCNA NuCana plc - American Depositary Shares | 1.13 USD | -0.88% | -5.83% | -19.29% | -47.44% | 4.70 M USD | ||
| 4848 |  XTLB XTL Biopharmaceuticals Ltd - American Depositary Shares | 1.98 USD | 0.00% | -8.76% | -18.85% | +120.00% | 4.68 M USD | ||
| 4857 |  ENLV Enlivex Ltd. - Ordinary Shares | 0.28 USD | -9.68% | -33.33% | -73.08% | -76.07% | 4.43 M USD | ||
| 4863 |  DRMA Dermata Therapeutics, Inc. - Common Stock | 1.07 USD | -4.46% | -7.76% | -13.71% | -25.17% | 4.30 M USD | ||
| 4864 |  PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.40 USD | -2.44% | -2.44% | -16.67% | -60.00% | 4.29 M USD | ||
| 4873 |  ERNA Ernexa Therapeutics Inc. - Common Stock | 2.49 USD | +4.18% | -17.00% | -40.71% | +611.43% | 4.06 M USD | ||
| 4878 |  ADXN Addex Therapeutics Ltd - American Depositary Shares | 3.18 USD | +6.71% | +4.26% | -13.35% | -63.78% | 3.92 M USD | ||
| 4886 |  PCSA Processa Pharmaceuticals, Inc. - Common Stock | 1.35 USD | -4.93% | -21.97% | -35.10% | -39.19% | 3.77 M USD | ||
| 4891 |  GRI GRI Bio, Inc. - Common Stock | 1.68 USD | -9.19% | -16.00% | -14.29% | -36.60% | 3.67 M USD | ||
| 4897 |  EVGN Evogene Ltd. - Ordinary Shares | 0.40 USD | -2.44% | -2.44% | -20.00% | -69.92% | 3.49 M USD | ||
| 4899 |  SXTP 60 Degrees Pharmaceuticals, Inc. - Common Stock | 0.97 USD | -11.82% | -24.22% | +3.19% | -40.85% | 3.41 M USD | ||
| 4901 |  CVKD Cadrenal Therapeutics, Inc. - Common Stock | 0.93 USD | -4.12% | -5.10% | -23.77% | -83.15% | 3.32 M USD | ||
| 4905 |  APVO Aptevo Therapeutics Inc. - Common Stock | 1.80 USD | -2.17% | 0.00% | -4.76% | -73.33% | 3.24 M USD | ||
| 4909 |  REVB Revelation Biosciences, Inc. - Common Stock | 0.78 USD | -6.02% | -3.70% | -23.53% | -43.48% | 3.11 M USD | ||
| 4912 |  MLEC Moolec Science SA - Ordinary Shares | 4.19 USD | -12.89% | -13.61% | -38.38% | +398.81% | 3.04 M USD | ||
| 4918 |  MBIO Mustang Bio, Inc. - Common Stock | 0.41 USD | -8.89% | -12.77% | -25.45% | -52.87% | 2.97 M USD |
Nachrichten Biotechnology Stocks
Pharvaris: HAE-Medikament zeigt in Lancet-Studie schnellere Symptomlinderung
Kymera Therapeutics: Raymond James startet Coverage mit „Outperform“-Rating
Raymond James startet Coverage für Nektar-Aktie mit "Market Perform"
Raymond James nimmt Coverage für Palisade Bio mit "Outperform" auf
Raymond James bestätigt Liquidia-Rating trotz rechtlicher Unsicherheiten
Ginkgo Bioworks gewährt NSF X-Labs Zugang zu autonomem Labor
AbCellera präsentiert Phase-1/2-Daten zu Medikamentenkandidaten gegen Menopause-Beschwerden
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |